Medical Marijuana Market Status & Trend Report 2018-2022 offers a comprehensive analysis on Medical Marijuana Market industry, standing on the reader’s perspective, delivering detailed market data in Global major countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information. Key questions answered by this report include:

Statistics Canada says Canadian spending on cannabis rose 1.1 per cent to roughly $5.9 billion on an annualized basis in the third quarter.

Nearly 84 per cent of purchases were illegal and for non-medical use, down from 98 per cent in mid-2014 as cannabis consumption for medical use has increased.

The agency estimates that of the $4.9 billion in illegal, non-medical pot purchases in the third quarter, roughly 1.9 per cent came from home production.

About $836 million was spent on medical cannabis during the period, including $88 million of personal production.

Household spending on cannabis has increased for six consecutive quarters, averaging a growth rate of 1.5 per cent.

Choom™ (CSE: CHOO) (OTCQB: CHOOF) (the "Company" or "Choom") an emerging adult use cannabis company that has secured one of the largest national retail networks in Canada, is pleased to announce it has acquired Clarity Cannabis Medical Centre Inc. and affiliates doing business as Clarity Medical Centres.

Chris Bogart, President & CEO states, "Our goal is to build a dominant national cannabis retail brand. The acquisition of Clarity Medical Centres allows Choom to service the entire Canadian cannabis market, beyond just the adult use channel. As cannabis becomes more widely accepted as an alternative to pharmaceuticals, increasingly, patients with medical conditions will require professional medical advice on the benefits and best use of cannabis as a treatment."

When Canada fully legalized recreational cannabis on Oct. 17, the internet giddily reimagined the CN Tower in Toronto peeking out from a thick haze and swapped the flag’s red maple leaf for its jagged-edged green cousin. Outsiders might titter about an entire populace turning into potheads, but legalization means some of the country’s brightest can now turn their minds to pot, writes Amanda Siebert from the New York Times.

Cronos Group, a vertically integrated marijuana company, has been doubling down on the cannabis oils space over the last few quarters as it looks to bolster margins and drive greater product differentiation. During Q3 2018, the company saw 29% of its revenue come from cannabis oils, up from levels of around 19% in the previous quarter. Below we take a look at some of the trends driving the company’s push into cannabis oils and what lies ahead.

Canada may have already legalized cannabis but the truth is that the cannabis market is only just beginning. Canadian legalization opened up a market estimated to be worth $5.7 billion CAD, which is expected to explode to $9.5 Billion by 2025. This figure is just a tiny piece of a global market predicted to be worth  $146.4 Billion USD by 2025.

Canada's roll out of its legal marijuana market has been a political victory for the Liberal government but with shortages of cannabis for sale at retailers — almost from day one — it has been a gift to illegal sellers.

One of the aims of the legalization of recreational marijuana was to eliminate the black market in Canada. The Liberal government wanted to remove the "criminal organizations, street gangs, and gun-runners" associated with the drug, said Prime Minister Justin Trudeau during the 2015 election campaign.

Last week, WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) announced the acquisition of a license from Health Canada to sell cannabis grown at its facility in Strathroy, Ontario. Under the terms of the license, the company can now transport cannabis from Strathroy to Aylmer, Ontario where they have indoor packaging and distribution space.

With 44,000-square-feet of space already approved, and another 60,000-square-feet awaiting the okay from Health Canada, WeedMD appears well on track to reach their production goals for the new year.

B.C.'s reputation as Canada's pot capital is stuck in red tape, while Albertans next door roll freely from store to store.

One month into legalization, Alberta has issued nearly 70 private retail licences, while British Columbia has issued one to a public retailer and another to a private store.

Bob Kay stopped selling marijuana from his Be Kind dispensary in Kelowna after legalization on Oct. 17, as he awaited his licence to operate as a store. Kay hopes to open four stores in the Okanagan — but at the moment he's still waiting, unsure about the status of his application. "I'm extremely frustrated," said Kay, who is still selling accessories at Be Kind.

Following the legalization of recreational marijuana, a growing number of Canadians are looking to experiment with cannabis for its medicinal properties. But with some doctors unwilling to prescribe the once-illicit drug, many patients are seeking clarity in the hazy world of weed by turning to nurses.

Like thousands of other Canadians, Gordon Bennett was prescribed opioids to ease his arthritis pain. But the problem, the 96-year-old says, was that they just didn’t work.

“I could hardly get out of bed,” Bennett told CTV News from his Ottawa home. “It was hell… I had pain in my back, I had pain in my neck, I had pain in my legs -- every part of my body suffered.”